Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
Want to see IN:SPARC full AI Analyst Report?
Total Valuation
Sun Pharma Advanced Research Co. Ltd. has a market cap or net worth of ₹58.56B. The enterprise value is ₹73.66B.
Market Cap₹58.56B
Enterprise Value₹73.66B
Share Statistics
Sun Pharma Advanced Research Co. Ltd. has 324,521,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding324,521,580
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sun Pharma Advanced Research Co. Ltd.’s return on equity (ROE) is 1.16 and return on invested capital (ROIC) is 80.40%.
Return on Equity (ROE)1.16
Return on Assets (ROA)0.72
Return on Invested Capital (ROIC)80.40%
Return on Capital Employed (ROCE)1.12
Revenue Per Employee45.95M
Profits Per Employee37.98M
Employee Count409
Asset Turnover0.87
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sun Pharma Advanced Research Co. Ltd. is 2.4. Sun Pharma Advanced Research Co. Ltd.’s PEG ratio is -0.00434.
PE Ratio2.4
PS Ratio1.98
PB Ratio2.78
Price to Fair Value2.78
Price to FCF-12.56
Price to Operating Cash Flow-58.76
PEG Ratio-0.00434
Income Statement
In the last 12 months, Sun Pharma Advanced Research Co. Ltd. had revenue of 18.79B and earned 15.53B in profits. Earnings per share was 47.86.
Revenue18.79B
Gross Profit17.27B
Operating Income15.89B
Pretax Income15.53B
Net Income15.53B
EBITDA15.99B
Earnings Per Share (EPS)47.86
Cash Flow
In the last 12 months, operating cash flow was -1.16B and capital expenditures -231.40M, giving a free cash flow of -1.39B billion.
Operating Cash Flow-1.16B
Free Cash Flow-1.39B
Free Cash Flow per Share-4.28
Dividends & Yields
Sun Pharma Advanced Research Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.78
52-Week Price Change28.49%
50-Day Moving Average142.48
200-Day Moving Average138.06
Relative Strength Index (RSI)77.85
Average Volume (3m)24.00K
Important Dates
Sun Pharma Advanced Research Co. Ltd. upcoming earnings date is Aug 10, 2026, TBA (Confirmed).
Last Earnings DateMay 18, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
Sun Pharma Advanced Research Co. Ltd. as a current ratio of 2.47, with Debt / Equity ratio of 41.78%
Current Ratio2.47
Quick Ratio2.47
Debt to Market Cap0.15
Net Debt to EBITDA0.35
Interest Coverage Ratio46.54
Taxes
In the past 12 months, Sun Pharma Advanced Research Co. Ltd. has paid -1.90M in taxes.
Income Tax-1.90M
Effective Tax Rate>-0.01
Enterprise Valuation
Sun Pharma Advanced Research Co. Ltd. EV to EBITDA ratio is 2.68, with an EV/FCF ratio of -14.44.
EV to Sales2.28
EV to EBITDA2.68
EV to Free Cash Flow-14.44
EV to Operating Cash Flow-15.70
Balance Sheet
Sun Pharma Advanced Research Co. Ltd. has ₹30.00M in cash and marketable securities with ₹4.17B in debt, giving a net cash position of -₹4.14B billion.
Cash & Marketable Securities₹30.00M
Total Debt₹4.17B
Net Cash-₹4.14B
Net Cash Per Share-₹12.75
Tangible Book Value Per Share₹39.06
Margins
Gross margin is 94.71%, with operating margin of 84.53%, and net profit margin of 82.65%.
Gross Margin94.71%
Operating Margin84.53%
Pretax Margin82.64%
Net Profit Margin82.65%
EBITDA Margin85.08%
EBIT Margin84.53%
Analyst Forecast
The average price target for Sun Pharma Advanced Research Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2518.32%
EPS Growth Forecast―